Northwestern Mutual Wealth Management
VRAX icon

Northwestern Mutual Wealth Management’s Virax Biolabs VRAX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio VRAX Stock Details VRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Hold
0
– -$3 – 4483
2025
Q4 		– Hold
0
– – – 3990
2025
Q1 		– Sell
-1
Closed -$45 – 3961
2024
Q4 		$45 Buy
+1
New +$48 ﹤0.01% 3521

Other funds holding VRAX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northwestern Mutual Wealth Management's VRAX Position: Q1 2026 in Review

Northwestern Mutual Wealth Management held its Virax Biolabs (VRAX) position steady in Q1 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4483.

Northwestern Mutual Wealth Management first reported a position in VRAX in Q4 2024 and has held it in 1 quarter since. The position peaked at $45 in Q4 2024. 4 funds tracked by Wall St. Rank hold VRAX as of Q1 2026.

  • Northwestern Mutual Wealth Management held 0 shares of Virax Biolabs worth $0 as of Q1 2026.
  • Northwestern Mutual Wealth Management left its Virax Biolabs share count unchanged in Q1 2026.
  • Virax Biolabs made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #4483 holding.
  • Northwestern Mutual Wealth Management first reported a position in Virax Biolabs in Q4 2024 and has held it in 1 quarter since.
  • Northwestern Mutual Wealth Management's Virax Biolabs position peaked at $45 in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Virax Biolabs as of Q1 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.